SIT LESS 2: Effect of Sitting Less on Glucose Regulation in People With Diabetes Mellitus Type 2

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

19 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-02-28

Study Completion Date

2015-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Introduction: Changes in lifestyle are responsible for an important part of the type 2 diabetes epidemic of the last decennia. Current guidelines for physical activity focus mainly on high energy expenditure advising 30 minutes per day moderate to vigorous physical activity (most often physical exercise). Recent studies suggest that sitting has negative metabolic effects independent of the time spent exercising (Duvivier et al. PLOS ONE 2013).

Low intensity physical activity (LIPA) -such as walking and standing- has been suggested to be an alternative to decrease the hyperglycaemic effect of sitting. Compared to exercise, LIPA might be a more feasible strategy. But, it remains to be determined whether reducing sitting time by replacing it by LIPA, results in lower 24 hour blood glucose levels and less blood glucose fluctuations (glycaemic variability) in type 2 diabetes patients and whether these effects are independent of the increase in energy expenditure

Methods: The study population will involve 19 people with type 2 diabetes (BMI: 25-35 kg/m2) who perform no, or only little, exercise and who are treated with diet only or with oral blood glucose lowering medication. They will perform three regimes of each four days: 1) a sitting regime, 2) an exercise regime and a 3) sit less regime. Daily energy expenditure of the exercise regime will be identical to that of the sit less regime. Sitting, walking and standing will be objectively measured by a 24 hour physical activity monitor. The energy spent during exercise will be standardised and quantified by using a bicycle ergometer; energy intake will be standardised as well. During each regime blood glucose will be measured with a 24 hour continuous glucose sensor.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Role of Interrupting Sedentary Time in Management of Type-2 Diabetes

NCT02738996

Diabetes

UNKNOWN NA

SIT LESS 4: How Does Reducing Sitting Time Improve Glucose and Lipid Metabolism?

NCT03912922

Overweight and Obesity

COMPLETED NA

Breaks in Sedentary Time and Glucose Regulation in Women

NCT02135172

Impaired Glucose Tolerance

COMPLETED NA

FIT 2 SIT - Are Metabolic Responses to Sitting/Light Breaks Mediated by Fitness?

NCT02493309

Diabetes

COMPLETED NA

24-hour Movement Behaviors Among Type 2 Diabetes Mellitus Patients

NCT04993482

Diabetes Mellitus, Type 2

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Type 2 Diabetes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Sitting regime

The subjects will follow the sitting regime during four days. Each day: 14 hours sitting, 1 hour walking and 1 hour standing for daily care and 8 hours sleeping or lying.

Group Type EXPERIMENTAL

Physical activity intervention

Intervention Type BEHAVIORAL

Sit Less regime

Subjects will follow the sit less regime during four days. Each day will consist of 3 hours walking, 4 hours standing, 9 hours sitting and 8 hours sleeping or lying. The additional 2 hours of walking and 3 hours of standing, compared to the sitting regime, will be done in a minimum of four bouts with a time interval of \> 1 hour. The subjects will be instructed to walk on a slow pace. i.e. 2-3 km/h, which is comparable to walking during shopping, walking to the office etc.

Group Type EXPERIMENTAL

Physical activity intervention

Intervention Type BEHAVIORAL

Exercise regime

Subjects will follow the exercise regime during four days. Each day will consist of 13 hours and 15 minutes sitting, ± 45 minutes supervised cycling on an ergometer, 1 hour walking and 1 hour standing for daily care and 8 hours sleeping or lying.

Group Type EXPERIMENTAL

Physical activity intervention

Intervention Type BEHAVIORAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Physical activity intervention

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Signed informed consent
* Men and women: 40-75 years old
* Diabetes mellitus type 2, developed after the age of 40 years old
* Treatment with diet or oral blood glucose lowering medication (metformin and/or SU-derivatives and/or DPP-IV inhibitors)
* HbA1c: \< 10%
* BMI: 25.0 - 35.0 kg/m2
* Maximum 2.5 hours of MVPA per week (during last 3 months)
* Internet availability on a daily basis

Exclusion Criteria

* Pregnancy or intention of becoming pregnant
* Alcohol use: \> 2 units per day (during the last 3 months)
* Experimental drug use (during the last 3 months)
* Use of insulin, corticosteroids, vitamin K antagonists and immunosuppressive drugs in the last 3 months
* Triglyceride level \> 10.0 mmol/L
* Fasting plasma glucose level \> 10 mmol/L
* Heart failure NYHA 3 or higher
* Angina pectoris or signs of cardiac ischemia during exercise testing
* COPD Gold 3 or higher
* Glomerular filtration rate (GFR) \< 30 ml/min
* Diagnosis of active cancer (not cancer in the past that is cured)
* Diabetes mellitus type 1
* Intermittent claudication with a walking distance \< 500 meter
* Not able to cycle for ± 45 minutes, as judged from the incremental exhaustive exercise bicycle-ergometer test at Visit 1
* Based on historical information not able to walk for 3 hours per day and stand for 4 hours per day
* Mental or physical disability which makes physical activity not possible
* Participation in a clinical trial with medication use (in the last 3 months)
* Severe loss of vision
* Active foot ulcer or venous leg ulcer

Minimum Eligible Age

40 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No